CLDI AMEX
Calidi Biotherapeutics, Inc.
1W: -4.4%
1M: -19.4%
3M: -55.0%
YTD: -94.3%
1Y: -95.9%
3Y: -100.0%
$1.08
+0.00 (+0.00%)
Weekly Expected Move ±11.3%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
9 relationships0
As Filer
counterparties named
9
As Counterparty
mentioned by others
2023-01-09
Earliest Filing
2025-10-31
Latest Filing
Mentioned As Counterparty
9 mentionsOther companies that named CLDI in their SEC 8-K filings.
| Filed By | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|
| CLDWW Calidi Biotherapeutics, Inc. | acquirer | Seller of repurchased shares | 2025-10-31 | View |
| CLDWW Calidi Biotherapeutics, Inc. | partner | Company issuing shares in the offering | 2025-01-10 | View |
| CLDWW Calidi Biotherapeutics, Inc. | acquirer | Company issuing convertible promissory note and warrants to raise working capital | 2024-02-01 | View |
| CLDWW First Light Acquisition Group, Inc. | acquirer | Target company in the proposed business combination with First Light Acquisition Group, Inc. | 2023-08-31 | View |
| CLDWW First Light Acquisition Group, Inc. | acquirer | Target company in the business combination with FLAG. | 2023-08-29 | View |
| CLDWW First Light Acquisition Group, Inc. | acquirer | Target company in the proposed business combination with First Light Acquisition Group, Inc. | 2023-06-23 | View |
| CLDWW First Light Acquisition Group, Inc. | acquirer | Target company in the proposed business combination with First Light Acquisition Group, Inc. | 2023-04-13 | View |
| CLDWW First Light Acquisition Group, Inc. | acquirer | Target company in the proposed business combination with First Light Acquisition Group, Inc. | 2023-02-10 | View |
| CLDWW First Light Acquisition Group, Inc. | acquirer | Target company in the business combination transaction with First Light Acquisition Group, Inc. | 2023-01-09 | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR